Source: Virtual Congress 2021 – Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Papi (Ferrara, Italy). How to treat asthma in 2021? Goodbye SABA, hello MART and welcome triple therapy. Virtual Congress 2021 – Airway diseases

Member's Comments

No comment yet.

Related content which might interest you: Optimising bronchodilator therapy in COPD: Who, why and when? Source: International Congress 2019 – Personalised medicine in COPD: Matching the patient needs with the right care Year: 2019 Can " Beta-blockers" be useful to treat asthma? Source: Annual Congress 2009 - Beta-blockers may now be beneficial in asthma and COPD Year: 2009 Long-acting bronchodilators in COPD: where are we now and where are we going? Source: Breathe 2014; 10:110-120 Year: 2014 How often do asthma patients claim prescribed therapy? Source: International Congress 2017 – Asthma from childhood to adulthood and ACOS Year: 2017 Inhaled therapies: can they breathe new life into asthma? Source: International Congress 2019 – The journey towards personalized medicine in asthma: where are we now? Year: 2019 Inhaled corticosteroids in COPD: friend or foe? Source: Eur Respir J, 52 (6) 1801219; 10.1183/13993003.01219-2018 Year: 2018 Late Breaking Abstract - Overprescription of short-acting beta2-agonists in asthma management? Pharmacy reports from 91,673 patients in Poland Source: International Congress 2019 – New towards old therapies in airway diseases Year: 2019 Making simple things complicated using anti-inflammatory reliever therapy Source: Eur Respir J, 55 (4) 2000267; 10.1183/13993003.00267-2020 Year: 2020 The sustainability agenda and inhaled therapy: what do patients want? Source: Virtual Congress 2021 – Asthma inhalers: new devices and adherence Year: 2021 LAMA/LABA vs. LABA/ICS and triple therapy – is ICS in again? Source: International Congress 2018 – Preventing asthma and COPD exacerbations by increasing the inhaled glucocorticoid dose Year: 2018 Budesonide/formoterol maintenance and reliever therapy for asthma in general practice: is it cost-effective? Source: Annual Congress 2008 - Diagnosing, monitoring and treating respiratory diseases in primary care Year: 2008 CPAP holiday: are we there yet? Source: Eur Respir J 2015; 45: 574-575 Year: 2015 Spacer devices for inhaled therapy: why use them, and how? Source: ERJ Open Res, 4 (2) 00065-2018; 10.1183/23120541.00065-2018 Year: 2018 CPAP holiday: are we there yet? Source: Eur Respir J 2015; 45: 575-576 Year: 2015 Late Breaking Abstract - Impact of maintenance and reliever therapy (MART)-focused asthma guideline on SABA prescriptions Source: Virtual Congress 2021 – Highlights for primary care in 2021 Year: 2021 “My reliever helps me control my asthma”: patient attitudes to asthma inhalers Source: International Congress 2018 – The complexities of managing mild asthma Year: 2018 What to use INSTEAD of inhaled corticosteroids in COPD? Source: Eur Respir J 2014; 44: 1391-1393 Year: 2014 Treating non-adherence: the rest is pointless if the drugs stay in the cupboard! Source: International Congress 2017 – Cystic fibrosis in children and adults: treatment dilemmas Year: 2017 Why isn't his asthma getting better Doctor? Source: ERS Live 2009 Year: 2009